LC-MS

BioAscent is a provider of integrated drug discovery services based at the former Organon/MSD R&D site in Newhouse, Scotland, UK. Founded in 2013, its services include assay development, target analysis, compound screening, medicinal and synthetic chemistry, computational chemistry, DMPK, protein science and compound management, with access to in-house diversity and fragment libraries.

assay developmentbiophysicscompound managementcompound screeningcompound storage and logisticscomputational chemistryDMPKhigh throughput screeningin silico discoveryliquid handlingmedicinal chemistryNMRprotein productionpurificationstructural biologysurface plasmon resonancesynthetic chemistry

CovalX is a trusted service provider for biologics, offering epitope mapping and full monoclonal antibody (mAb) analytics by mass spectrometry. Its vision is to become a leading provider of technology and services in epitope mapping and protein interaction analysis.

biophysical testingBLIde-novo sequencingdisulfide mappingepitope mappingglycan analysisHDX-MShost cell protein analysisimmunoprecipitation mass spectrometrymAb characterizationMALDI-MSmass spectrometrySPRXL-MS

Emery Pharma is a full-service Contract Research Organization (CRO) and GLP/cGMP-compliant contract research laboratory based in Alameda, California. It supports preclinical drug development with analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and general R&D and cGMP/GLP support, delivering customized solutions to fit clients' outsourcing needs.

analytical method developmentbioanalytical assaysbiologics characterizationELISA and MSD immunoassaysGC-MSGLP/cGMP compliancehigh-resolution mass spectrometryHPLC/UPLCLC-MS/MSmetabolomicsmethod transfermethod validationmicrobiology testingNMRproteomicsstability testing